Shelter Pharma Ltd

BSE: 543963

₹32.75

up-down-arrow1.05 (3.31%)

As on 28-Aug-2026IST

Market cap

info icon

₹55 Cr

Revenue (TTM)

info icon

₹51 Cr

P/E Ratio

info icon

6.1

P/B Ratio

info icon

0.9

Div. Yield

info icon

0 %

Shelter Pharma Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 32.50 High: 34.40

52 Week Range

Low: 23.00 High: 46.98

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹7 Cr

  • ROEROE information

    18.9 %

  • ROCEROCE information

    25.1 %

  • Industry P/EIndustry P/E information

    39.17

  • EV/EBITDAEV/EBITDA information

    4.1

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹36.1

  • EPSEPS information

    ₹6.3

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    16,836,792

10 Years Aggregate

CFO

₹2.67 Cr

EBITDA

₹29.90 Cr

Net Profit

₹20.81 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Shelter Pharma
-10.9 21.0 9.2 -30.9 -7.3 -- --
BSE Healthcare
18.8 2.8 8.7 17.1 23.1 14.8 12.4
As on 28-Aug-2026
Company
2025
2024
Shelter Pharma
-34.5 -3.4
BSE Small Cap
-6.6 29.0
BSE Healthcare
-3.3 43.1

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Shelter Pharma
32.8 55.1 50.7 7.2 -- 18.9 6.1 0.9
1,350.2 16,589.5 2,590.4 603.0 29.3 19.6 27.5 4.8
577.7 10,912.7 885.7 234.9 27.8 18 46.5 4.9
1,481.1 15,506.7 1,108.4 270.2 28.3 14.5 56.3 7.5
1,869.4 35,497.5 9,683.5 1,019.0 15.7 21.3 35.1 6.8
23,205.0 29,798.0 2,371.8 497.8 28.0 28.5 59.9 14.7
975.6 5,827.4 942.6 9.9 0.3 1.2 672.4 4.5
1,482.1 6,826.8 691.7 130.8 24.5 14.5 54 7.1
1,152.1 13,020.2 675.6 183.6 32.2 22.7 71.3 14.1
365.0 10,310.7 8.8 -352.4 -4,228.0 -80.8 -- 18.5

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Shelter Pharma

Manufacture of pharmaceuticals, medicinal chemical and botanical products

  • Incorporated

    2007

  • Chairman

    --

  • Managing Director

    Mustaqim Nisarahmed Sabugar

  • Headquarters

    Himatnagar, Gujarat

  • Website

    www.shelter.co.in

FAQs for Shelter Pharma

The share price of Shelter Pharma Ltd is ₹32.75 (BSE) as of 28-Aug-2026 IST. Shelter Pharma Ltd has given a return of -7.26% in the last 3 years.

The P/E ratio of Shelter Pharma Ltd is 6.11 times as on 28-Aug-2026, a 84 discount to its peers’ median range of 39.17 times.
The P/B ratio of Shelter Pharma Ltd is 0.91 times as on 28-Aug-2026, a 75 discount to its peers’ median range of 3.61 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
5.78
1.00
2024
9.17
1.63
2023
0.00
0.00
2022
0.00
0.00
2021
0.00
0.00

The 52-week high and low of Shelter Pharma Ltd are Rs 46.98 and Rs 23.00 as of 30-Aug-2026.

Shelter Pharma Ltd has a market capitalisation of ₹ 55 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Shelter Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...